𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Partial allelotype of schistosomiasis-associated bladder cancer

✍ Scribed by Margaret E. Shaw; Patricia A. Elder; Ahmed Abbas; Margaret A. Knowles


Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
142 KB
Volume
80
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


In Egypt and other regions of the Middle East where the trematode Schistosoma haematobium is endemic, bladder cancer is the most common adult cancer. Unlike bladder cancers in Western countries, which are predominantly transitional-cell carcinoma (TCC), these schistosomiasisassociated bladder cancers are predominantly squamous-cell carcinoma (SCC). Our aim was to assess a large series of schistosomiasis-associated bladder tumours for genetic alterations commonly found in TCC in the United Kingdom and the United States. We have carried out a partial allelotype of 70 tumours from patients with schistosomiasis. LOH was found on all chromosome arms studied (3p, 4p, 4q, 8p, 9p, 9q, 11p, 11q, 13q, 14q, 17p, 18q). The most frequent regions of LOH were 9p (65%), 17p (58%), 3p (40%), 9q (39%) and 8p (37%). LOH on 17p, where the TP53 gene is located, was more common in Egyptian TCC than in SCC. Similarly, 8p LOH was more common in TCC than SCC. The most striking difference between this group of tumours and TCCs from the United Kingdom and the United States was the high frequency of 9p LOH in the region of the CDKN2 gene (65%) and the relatively low frequency of 9q LOH (39%); 15 of 43 tumours with LOH of at least one marker on chromosome 9 showed LOH of 9p only. This suggests that a 9p gene, possibly CDKN2, may contribute to the development of the majority of schistosomiasis-associated bladder tumours but that genes on 9q play a much less important role.


πŸ“œ SIMILAR VOLUMES


Genetic and phenotypic changes associate
✍ John J. Gildea; Wendy L. Golden; Michael A. Harding; Dan Theodorescu πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 2 views

There has been a general lack of human paired cell lines that both reproduce the in vivo spectrum of tumor progression of bladder cancer and have some of the genetic changes associated with progression in human tumor tissue. T24, a cell line established from an invasive human transitional cell carci

Allelic changes at multiple regions of c
✍ von Knobloch, Rolf; Bugert, Peter; Jauch, Anna; KοΏ½lble, Tilman; Kovacs, Gyula πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 226 KB πŸ‘ 1 views

This study has analysed 65 urothelial carcinomas for allelic imbalance at 22 loci of chromosome 5 and has determined three regions of interest. A commonly duplicated region was mapped to chromosome 5p between loci D5S1473 and D5S819, one region of deletion to chromosome 5q22Β±23 between loci D5S2055

PMA-induced reduction in invasiveness is
✍ Yasuhiro Yokoyama; Tetsushi Ito; Veneta Hanson; Gary K. Schwartz; Alan A. Aderem πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 159 KB πŸ‘ 2 views

Protein kinase C (PKC) plays a critical role in signal transduction for a variety of cell activation processes. Enhanced PKC activity is often found in cancer cells that show marked invasive and/or metastatic potential. Thus, a specific PKC inhibitor may serve as a tool to reduce invasive or metasta

In vitro cytotoxicity following specific
✍ Konstantinos N. Syrigos; Gail Rowlinson-Busza; Agamemnon A. Epenetos πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 111 KB

We describe a novel version of antibody-directed enzyme prodrug therapy (ADEPT), with the use of amygdalin as prodrug. Amygdalin is a naturally occurring cyanogenic glycoside, which can be cleaved by sweet almond ␀-glucosidase to yield free cyanide. If amygdalin could be activated specifically at th

Localization of tumor suppressor gene as
✍ Kenji Ohgaki; Aritoshi Iida; Osamu Ogawa; Yoshinobu Kubota; Masao Akimoto; Mitsu πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

To identify the location of one or more putative tumor suppressor genes that may be involved in urinary bladder cancer, we examined 82 such tumors for allelic losses at 19 microsatellite loci on 8p. Loss of heterozygosity was observed in 31 of the cases. Deletion mapping identified a commonly delete